Advertisement

MUHC becomes first hospital in the world to try new catheter procedure

Click to play video: 'MUHC first to try catheter procedure'
MUHC first to try catheter procedure
WATCH ABOVE: The MUHC is the first hospital in the world to perform a chronic total occlusion (CTO) percutaneous coronary intervention procedure using a new device, the TrapLiner, for the first time in the world – Dec 13, 2016

The McGill University Hospital Centre (MUHC) has become the first in the world to try a new technology that will improve how surgeons treat clogged arteries.

The device, which was approved by Health Canada, is called TrapLiner and was first used on Tuesday. It will be used for procedures on patients suffering from chronic total occlusion (OTC).

Receive the latest medical news and health information delivered to you every Sunday.

Get weekly health news

Receive the latest medical news and health information delivered to you every Sunday.
By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy.

TrapLiner is a technology developed by Vascular Technology, Inc. The technology is also expected to reduce the amount of time the patient is on the operating table.

The MUHC said it was chosen to conduct the first procedure because of the reputation the catheterization laboratories – headed by Dr. Stéphane Rinfret – has garnered.

“Few centres in Canada have developed the expertise in treating patients with [OTC],” Rinfret said. “It’s sort of a super-specialized activity out of many activities we can do.”
Story continues below advertisement

Rinfret added he hopes the technology will spread across the country to help patients with OTC.

Sponsored content

AdChoices